Conference Coverage
Conference Coverage
Systemic sclerosis brings sharply increased MI risk
Major finding: The incidence rate of acute MI following diagnosis of systemic sclerosis was 20.2 events per 1,000 person-years, compared with 5.3...
Conference Coverage
Treatment adherence poor among Medicaid beneficiaries with lupus
Major finding: Among Medicaid beneficiaries with SLE, the average medication possession ratio ranged from 31.1% for tacrolimus to 56% for...
Conference Coverage
Apremilast promising for Behçet’s syndrome
Major finding: The mean number of oral ulcers in Behçet’s syndrome patients treated with apremilast quickly dropped from 2.8 at baseline to 0.5,...
Conference Coverage
Obesity paradox may exist in hypertensive patients with diabetes
Major finding: The primary endpoint of major cardiovascular events was reached in 42 (15%) patients in the lowest BMI category (Q1), compared with...
Conference Coverage
Systemic sclerosis overlap syndromes called distinct entity
Major finding: Musculoskeletal involvement occurred in 67% of patients with systemic sclerosis overlap syndromes, compared with 38% of those with...
Conference Coverage
Remote monitoring reduced death in advanced heart failure
Major finding: At 1-year, the mortality of home monitoring group was 3.4%, compared with 8.7% in patients receiving standard care (P = .004).Data...
Conference Coverage
Azelaic acid 15% gel tames women’s acne
Major finding: Azelaic acid 15% gel and adapalene 0.1% gel displayed comparable efficacy in treating women with adult acne, with median scores on...
Conference Coverage
Atomoxetine may lead to improved driving for adults with ADHD
Major finding: After 8 weeks treatment with atomoxetine, attention-deficit/hyperactivity disorder patients showed significant improvement over...
Conference Coverage
Treatment options expand for pulmonary arterial hypertension in scleroderma
Conference Coverage
MSSA patients tolerate cefazolin over nafcillin
Major finding: Overall discontinuation for nafcillin vs. cefazolin: 34% vs. 7%, respectivelyData source: A retrospective cohort study involving...
Conference Coverage
Breast cancer hormone therapy may affect cognitive function
Major finding: The odds of any decline in cognitive function were significantly higher in patients on hormone therapy (OR, 7.7), compared with...